<img height="1" width="1" style="display:none" src="https://www.facebook.com/tr?id=780280282443813&amp;ev=PageView&amp;noscript=1">
search

    Agios Pharmaceuticals, Inc.

    verified_userVerify Profile
    Companies » Health Care » Pharmaceuticals & Biotechnology » Pharmaceuticals

    About Agios Pharmaceuticals, Inc.

    Agios is a biopharmaceutical company passionately committed to applying our scientific leadership in the field of cellular metabolism to transform the lives of patients with cancer and rare genetic diseases. Source

    At A Glance

    • CAPITAL RAISE STATUS
      Not Currently Raising
    • FILING TYPE
      Public
    • PLATFORM TYPE
      NASDAQ
    • RAISED AMOUNT
      $X,XXX,XXX
    • PRE-MONEY EVAULATION
      $542,000,000
    • SIC CODE
      2834
    • NIN CODE
      ####
    • LEADERSHIP
      Jacqualyn Fouse, Ph.D.
    • FOUNDED
      2008
    • EMPLOYEES
      251-500
    • SECTOR
      Pharmaceuticals & Biotechnology
    • SUBSECTOR
      Pharmaceuticals

    Company Tags

    No articles found.

    Axcella Health Inc.

    Axcella Health Inc.

    Axcella is designing and developing AXA Candidates, compositions of endogenous met...

    Axcella is designing and developing AXA Candida...

    Filing Type:    PU
    OpGen, Inc.

    OpGen, Inc.

    OpGen, Inc. is a precision medicine company harnessing the power of molecular diag...

    OpGen, Inc. is a precision medicine company har...

    Filing Type:    PU
    Voyager Therapeutics, Inc.

    Voyager Therapeutics, Inc.

    Voyager Therapeutics is developing life-changing gene therapies for fatal and debi...

    Voyager Therapeutics is developing life-changin...

    Filing Type:    PU
    HOOKIPA Pharma Inc.

    HOOKIPA Pharma Inc.

    HOOKIPA Pharma Inc. is a clinical stage biopharmaceutical company developing a new...

    HOOKIPA Pharma Inc. is a clinical stage biophar...

    Filing Type:    PU
    Alnylam Pharmaceuticals, Inc.

    Alnylam Pharmaceuticals, Inc.

    Alnylam is leading the translation of RNA interference (RNAi) into a whole new cla...

    Alnylam is leading the translation of RNA inter...

    Filing Type:    PU
    Strongbridge Biopharma plc

    Strongbridge Biopharma plc

    Strongbridge Biopharma is a global commercial-stage biopharmaceutical company focu...

    Strongbridge Biopharma is a global commercial-s...

    Filing Type:    PU
    NeoGenomics, Inc.

    NeoGenomics, Inc.

    NeoGenomics, Inc. is a high-complexity CLIA-certified clinical laboratory and phar...

    NeoGenomics, Inc. is a high-complexity CLIA-cer...

    Filing Type:    PU
    DelMar Pharmaceuticals, Inc.

    DelMar Pharmaceuticals, Inc.

    DelMar Pharmaceuticals is a biopharmaceutical company focused on the development a...

    DelMar Pharmaceuticals is a biopharmaceutical c...

    Filing Type:    PU
    Verastem, Inc.

    Verastem, Inc.

    Verastem Oncology (Nasdaq: VSTM) is a commercial biopharmaceutical company committ...

    Verastem Oncology (Nasdaq: VSTM) is a commercia...

    Filing Type:    PU
    ©2026 National Investor Network. All Rights Reserved.